Jonathan E Lim
CIK 1283290 · Chairman & CEO · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$282.19M
Companies
5
Total Filings
52
Lifetime Open-Market Net
$2.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MAZE | Director | 328,700 | $24.05 | $7.91M | $0 | 3 | 2026-06-10 |
| ERAS | Chairman & CEO | 19,456,216 | $14.05 | $273.36M | $4.71M | 13 | 2026-01-30 |
| BOLD | Director | 653,479 | $1.41 | $921.4K | $0 | 4 | 2025-06-23 |
| Ignyta, Inc. (RXDX) Delisted | President, CEO and Director | 3,529,661 | $199.92 | $705.65M | $464.5K | 12 | 2017-12-28 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Chief Executive Officer | 710,000 | — | — | -$3.00M | 19 | 2010-02-08 |
Recent Filings · Page 4 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-24 | Ignyta, Inc. (RXDX) Delisted | Buy (P) | +20,000 | $180.2K | EDGAR |
| 2015-01-09 | Ignyta, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-19 | Ignyta, Inc. (RXDX) Delisted | Buy (P) | +5,000 | $38.0K | EDGAR |
| 2010-02-08 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-01-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +30,000 | $11.7K | EDGAR |
| 2009-02-09 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-24 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −250,000 | -$1.51M | EDGAR |
| 2008-03-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +230,000 | $89.7K | EDGAR |
| 2008-02-08 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-04 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | — | -$157.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.